Table 2 Ablation strategy and success rate of ablation block.
Bioprosthetic MVR group | Mechanical MVR group | p value | |
|---|---|---|---|
Lesion set | |||
Circumferential PV isolation | 21/21 (100%) | 85/85 (100%) | 1.000 |
Mitral isthmus line | 14/21 (66.7%) | 56/85 (65.9%) | 0.946 |
LA Roofline | 14/21 (66.7%) | 67/85 (78.8%) | 0.240 |
Cavotricuspid isthmus line | 17/21 (81.0%) | 73/85 (85.9%) | 0.572 |
CFAEs | 6/21 (28.6%) | 8/85 (9.4%) | 0.050 |
Marshall | 5/21 (23.8%) | 10/85 (11.8%) | 0.156 |
CS | 5/21 (23.8%) | 30/85 (35.3%) | 0.316 |
Bidirectional block achievement | |||
Circumferential PV isolation | 21/21 (100%) | 85/85 (100%) | 1.000 |
Mitral isthmus line | 11/14 (78.6%) | 39/56 (69.6%) | 0.508 |
LA roofline | 12/14 (85.7%) | 65/67 (97.0%) | 0.273 |
Cavotricuspid isthmus line | 17/17 (100.0%) | 69/73 (94.5%) | 0.738 |
